Navigation Links
Endo Pharmaceuticals Reports Second Quarter Revenues and Updates Financial Guidance, Reflecting the Acquisition of American Medical Systems
Date:8/9/2011

>$  43,239$  94,699DILUTED EARNINGS PER SHARE

$  0.44$  0.81DILUTED WEIGHTED AVERAGE SHARES

116,660116,660Notes to reconciliation of our GAAP statements of operations to our adjusted statements of operations:(1) To exclude amortization of commercial intangible assets related to marketed products.

(2) To exclude certain costs incurred with connection with continued efforts to enhance the Company's operations.

(3) To exclude milestone and upfront payments to partners.

(4) To exclude an impairment of other intangible assets.

(5) To exclude acquisition-related costs of $4,566 as well as the impact, under purchasing accounting, of a loss recorded to reflect the change in the company's current estimate of fair value, in accordance with GAAP, of the contingent consideration associated with the Indevus acquisition of $230.

(6) To exclude additional interest expense as a result of adopting ASC 470-20 of $4,306 and to exclude amortization of the premium on debt acquired from Indevus of ($94).

(7) To exclude changes in fair value of financial instruments, net.

(8) To reflect the cash tax savings resulting from the Indevus acquisition and the tax effect of the pre-tax adjustments above at applicable tax rates.  The following tables provide a reconciliation of our reported (GAAP) statements of operations to our adjusted statements of operations for each of the six months ended June 30, 2011 and June 30, 2010 (in thousands, except per share data): Six Months Ended June 30, 2011 (unaudited)Actual
Reported
(GAAP)AdjustmentsAdjustedREVENUES

$  1,167,637

$  —$  1,167,637COSTS AND EXPENSES: Cost of revenues

468,255

(103,015)

(1)

365,240 Selling, general and administrative

337,519

(4,416)

(2)

333,103 Research and development

82,970

(15,991)

(3)

<
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... November 2014 Clementia ... gegeben, dass die Europäische Arzneimittel-Agentur (European ... als Orphan-Medizinprodukt an Palovarotene vergeben hat, ... Behandlung von Fibrodysplasia ossificans progressiva (FOP). ... genetische Krankheit, die von schmerzhaften, wiederkehrenden ...
(Date:11/21/2014)... , Nov. 21, 2014 ... European Medicines Agency (EMA) has granted Orphan ... lead product candidate, for the treatment of ... rare, severely disabling genetic disease characterized by ... (flare-ups) and new abnormal bone formation. This ...
(Date:11/21/2014)... Ohio and MELVILLE, N.Y. ... CAH ), one of the world,s largest ... HSIC ), the world,s largest provider of ... health and medical practitioners, today announced that the companies ... one of the most comprehensive service and product offerings ...
Breaking Medicine Technology:Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 2Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 3Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 2Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 3Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 2Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 3Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 4Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 5
(Date:11/21/2014)... (PRWEB) November 21, 2014 Center for ... workshops titled “Massachusetts Insurance Funding for Autism Workshops” to ... navigate their way through the insurance coverage process. ... Massachusetts law and the most effective ways to access ... Dec. 4 from 6-8:00 p.m. at 331 Montvale Ave., ...
(Date:11/21/2014)... Mo (PRWEB) November 21, 2014 ... the Get With The Guidelines®–Heart Failure Gold-Plus Quality ... outlined by the American Heart Association/American College of ... heart failure patients. , Get With The Guidelines–Heart ... hospital teams provide the most up-to-date, research-based guidelines ...
(Date:11/21/2014)... Columbus, OH (PRWEB) November 21, 2014 ... their contract with the Ohio Chapter, American Academy of ... and provide safe sleep education to parents and caregivers ... and continues through June 30, 2015, provides $75,000 to ... , “The Ohio Children’s Trust Fund is excited to ...
(Date:11/21/2014)... 2014 Big Bud Farms announced today ... of Innovations with Ed Begley Jr., airing via Discovery ... , Big Bud Farms, growers of legal medical marijuana, ... utilization of medical marijuana. , This segment of Innovations ... variety of products for medicating. Viewers will learn about ...
(Date:11/21/2014)... The typical Thanksgiving dinner table is crowded ... gravy and a myriad of mouthwatering desserts. Who would ... year to begin losing weight? Listen closely. With a ... to losing unhealthy, embarrassing and uncomfortable fat while still ... insight to Diet Doc’s calorie loading holiday diet ...
Breaking Medicine News(10 mins):Health News:Center for Autism and Related Disorders to Host Massachusetts Autism Insurance Workshops for Parents 2Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 2Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 3Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 4Health News:Ohio AAP and Ohio Children’s Trust Fund Continue Partnership for Safe Sleep Education Campaign 2Health News:Ohio AAP and Ohio Children’s Trust Fund Continue Partnership for Safe Sleep Education Campaign 3Health News:Big Bud Farms to be Featured in Upcoming Episode of Innovations with Ed Begley Jr. 2Health News:Diet Doc Releases New Calorie Loading Diet Plans - the Perfect Way to Jump Start the Metabolism and Begin Weight Loss During Thanksgiving 2Health News:Diet Doc Releases New Calorie Loading Diet Plans - the Perfect Way to Jump Start the Metabolism and Begin Weight Loss During Thanksgiving 3Health News:Diet Doc Releases New Calorie Loading Diet Plans - the Perfect Way to Jump Start the Metabolism and Begin Weight Loss During Thanksgiving 4
... NEW YORK, February 22 NexGen Biofuels Ltd.,(NASDAQ: ... its symbol to,"NXGN"., The company has changed its ... HCTL to NXGN, to more clearly reflect its new ... and to produce such,fuel through the acquisition of existing ...
... MELVILLE, N.Y., Feb. 22 /PRNewswire-FirstCall/-- Gentiva Health,Services, Inc. ... of,comprehensive home health and related services, announced today ... to 3:55 p.m. ET, Monday, March 3, 2008,at ... in,Orlando, Florida., The event will be available ...
... Calif., Feb. 22 Sutter Health is creating ... care and specialist,physicians committed to providing patients with ... The Sutter Medical Network,will have a presence in ... from Sonoma County to the Central Valley and ...
... Inclinix, Inc., an enrollment,contract research organization (CRO) and provider ... its,executive management team:, -- Steven M. Agnoff, has ... President of Marketing and Product Management. In this ... to the corporate marketing and product ...
... Physicians Coalition,for Injectable Safety has issued a statement ... after reports of serious complications,following treatment with Botox ... Botox(R) injections for cosmetic indications or,who are considering ... recent reports of adverse events, but must put ...
... IT, Sales and Large-Project Management ... Provider,s Partner Channel, BLOOMFIELD HILLS, Mich., Feb. ... (EHR) software and practice,management solutions provider serving healthcare ... has joined,gloStream,s executive management team as chief channel ...
Cached Medicine News:Health News:Gentiva(R) Health Services to Present March 3rd at Raymond James' 29th Annual Institutional Investors Conference in Orlando 2Health News:Gentiva(R) Health Services to Present March 3rd at Raymond James' 29th Annual Institutional Investors Conference in Orlando 3Health News:Sutter Health Launches Northern California Physician Network 2Health News:Sutter Health Launches Northern California Physician Network 3Health News:Inclinix, Inc. Announces Executive Management Team Changes 2Health News:Clarity for Consumers on Botox Complication and Death Reports 2Health News:Clarity for Consumers on Botox Complication and Death Reports 3Health News:Clarity for Consumers on Botox Complication and Death Reports 4Health News:Nationally Recognized Information Technology Veteran and Entrepreneur John Bamberger Joins gloStream, Inc. as Chief Channel Officer 2
Disposable tracheostomy care tray....
Disposable tracheostomy care tray....
... Solution For Your Tracheostomy Care Needs, ... features the latest components for efficient and ... task. Designed by clinicians, these latex-free trays ... patient and caregiver. All of our trays ...
... and alternate care facilities with a ... which offer the finest in nursing ... the guidance of experienced nursing personnel, ... what is required for efficient and ...
Medicine Products: